Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy
Prasun K. Datta, Fengming Liu, Tracy Fischer, et al.
Theranostics (2020) Vol. 10, Iss. 16, pp. 7448-7464
Open Access | Times Cited: 243

Showing 1-25 of 243 citing articles:

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
Denis Y. Logunov, Inna V. Dolzhikova, Olga V. Zubkova, et al.
The Lancet (2020) Vol. 396, Iss. 10255, pp. 887-897
Open Access | Times Cited: 1069
SARS-CoV-2 Infectivity and Neurological Targets in the Brain
Walter J. Lukiw, Aileen I. Pogue, James M. Hill
Cellular and Molecular Neurobiology (2020) Vol. 42, Iss. 1, pp. 217-224
Open Access | Times Cited: 210
Controlling Cytokine Storm Is Vital in COVID-19
Lu Tang, Zhinan Yin, Yu Hu, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 173
COVID-19: Progress in diagnostics, therapy and vaccination
Xue Liu, Chao Liu, Gang Liu, et al.
Theranostics (2020) Vol. 10, Iss. 17, pp. 7821-7835
Open Access | Times Cited: 149
SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro
Fengming Liu, Kun Han, Robert V. Blair, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 136
The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication
Qin Ning, Di Wu, Xiaojing Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 73
COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges
Anup Singh Pathania, Philip Prathipati, Abdul Bakrudeen Ali Ahmed, et al.
Theranostics (2020) Vol. 11, Iss. 2, pp. 731-753
Open Access | Times Cited: 115
Endothelial cell infection and dysfunction, immune activation in severe COVID-19
Zhongnan Qin, Fengming Liu, Robert V. Blair, et al.
Theranostics (2021) Vol. 11, Iss. 16, pp. 8076-8091
Open Access | Times Cited: 99
The 2020 race towards SARS-CoV-2 specific vaccines
Tomasz M. Karpiński, Marcin Ożarowski, Agnieszka Seremak‐Mrozikiewicz, et al.
Theranostics (2020) Vol. 11, Iss. 4, pp. 1690-1702
Open Access | Times Cited: 91
Beneficial Properties of Bromelain
Paweł Hikisz, Joanna Bernasińska
Nutrients (2021) Vol. 13, Iss. 12, pp. 4313-4313
Open Access | Times Cited: 79
ACE2, COVID-19 Infection, Inflammation, and Coagulopathy: Missing Pieces in the Puzzle
Zaid Abassi, Abd Al Roof Higazi, Safa Kinaneh, et al.
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 71
Platelets and COVID-19
Anne‐Katrin Rohlfing, Dominik Rath, Tobias Geisler, et al.
Hämostaseologie (2021) Vol. 41, Iss. 05, pp. 379-385
Open Access | Times Cited: 69
Micronutrients, Phytochemicals and Mediterranean Diet: A Potential Protective Role against COVID-19 through Modulation of PAF Actions and Metabolism
Paraskevi Detopoulou, Constantinos A. Demopoulos, Smaragdi Antonopoulou
Nutrients (2021) Vol. 13, Iss. 2, pp. 462-462
Open Access | Times Cited: 65
Thrombosis and thrombocytopenia in COVID-19 and after COVID-19 vaccination
Toshiaki Iba, Jerrold H. Levy
Trends in Cardiovascular Medicine (2022) Vol. 32, Iss. 5, pp. 249-256
Open Access | Times Cited: 63
Potential Role of Antioxidant and Anti-Inflammatory Therapies to Prevent Severe SARS-Cov-2 Complications
Anna Maria Fratta Pasini, Chiara Stranieri, Luciano Cominacini, et al.
Antioxidants (2021) Vol. 10, Iss. 2, pp. 272-272
Open Access | Times Cited: 61
A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant
Mengxin Zhang, Ying Liang, Dongsheng Yu, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 2, pp. 889-900
Open Access | Times Cited: 61
COVID-19 disrupts the blood–testis barrier through the induction of inflammatory cytokines and disruption of junctional proteins
Tahmineh Peirouvi, Abbas Aliaghaei, Bahram Eslami Farsani, et al.
Inflammation Research (2021) Vol. 70, Iss. 10-12, pp. 1165-1175
Open Access | Times Cited: 57
COVID-19 in Joint Ageing and Osteoarthritis: Current Status and Perspectives
Marianne Lauwers, Man Ting Au, Shuofeng Yuan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 720-720
Open Access | Times Cited: 50
Mechanism of COVID-19 Causing ARDS: Exploring the Possibility of Preventing and Treating SARS-CoV-2
Jiajing Zheng, Jiameng Miao, Rui Guo, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 39
Lung Expression of Human Angiotensin-Converting Enzyme 2 Sensitizes the Mouse to SARS-CoV-2 Infection
Kun Han, Robert V. Blair, Naoki Iwanaga, et al.
American Journal of Respiratory Cell and Molecular Biology (2020) Vol. 64, Iss. 1, pp. 79-88
Open Access | Times Cited: 58
Classical and alternative receptors for SARS‐CoV‐2 therapeutic strategy
Siti Fathiah Masre, Nurul Farhana Jufri, Farah Wahida Ibrahim, et al.
Reviews in Medical Virology (2020) Vol. 31, Iss. 5, pp. 1-9
Open Access | Times Cited: 57
Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19
Jacques Fantini, Henri Chahinian, Nouara Yahi
Biochemical and Biophysical Research Communications (2020) Vol. 538, pp. 132-136
Open Access | Times Cited: 54
Oral Mucosa, Saliva, and COVID-19 Infection in Oral Health Care
Devi Sewvandini Atukorala Atukorallaya, Ravindra Kumar Ratnayake
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 49
Angiotensin II Type 2 Receptor: A Target for Protection Against Hypertension, Metabolic Dysfunction, and Organ Remodeling
Naureen Fatima, Sanket Patel, Tahir Hussain
Hypertension (2021) Vol. 77, Iss. 6, pp. 1845-1856
Open Access | Times Cited: 49
SARS-CoV-2 and Variant Diagnostic Testing Approaches in the United States
Emmanuel Thomas, Stephanie Delabat, Yamina Carattini, et al.
Viruses (2021) Vol. 13, Iss. 12, pp. 2492-2492
Open Access | Times Cited: 47
Page 1 - Next Page

Scroll to top